Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $207.57 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.73 | 4 | $0 (2021) |
| QOL Medical, LLC | $53.53 | 3 | $0 (2023) |
| RedHill Biopharma Inc. | $37.31 | 2 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $24.63 | 1 | $0 (2021) |
| Cumberland Pharmaceuticals, Inc. | $20.37 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $73.90 | 4 | QOL Medical, LLC ($53.53) |
| 2022 | $16.44 | 1 | RedHill Biopharma Inc. ($16.44) |
| 2021 | $66.08 | 3 | Intercept Pharmaceuticals, Inc. ($24.63) |
| 2020 | $51.15 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($51.15) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2023 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 08/02/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $6.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/01/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $24.67 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/14/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $22.51 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/11/2022 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Opioid Antagonist | ||||||
| 11/11/2021 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Opioid Antagonist | ||||||
| 10/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Gastroenterology | ||||||
| 06/25/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 10/14/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 383 | 742 | $1.7M | $38,619 |
| 2022 | 4 | 181 | 184 | $1.2M | $21,812 |
| 2021 | 4 | 160 | 162 | $1.4M | $20,194 |
| 2020 | 4 | 168 | 175 | $527,644 | $21,389 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 151 | 161 | $785,600 | $17,112 | 2.2% |
| 00812 | Anesthesia for exam of colon using an endoscope | Office | 2023 | 102 | 103 | $351,077 | $10,173 | 2.9% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 59 | 61 | $247,716 | $5,790 | 2.3% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Office | 2023 | 45 | 45 | $249,801 | $5,512 | 2.2% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 26 | 372 | $20,400 | $31.57 | 0.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2022 | 58 | 60 | $323,300 | $6,863 | 2.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Office | 2022 | 50 | 50 | $329,414 | $5,871 | 1.8% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Office | 2022 | 45 | 45 | $389,185 | $5,784 | 1.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2022 | 28 | 29 | $137,087 | $3,295 | 2.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 54 | 55 | $495,125 | $7,241 | 1.5% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2021 | 50 | 50 | $386,925 | $5,856 | 1.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2021 | 32 | 32 | $302,925 | $4,405 | 1.5% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 24 | 25 | $173,183 | $2,691 | 1.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 81 | 85 | $220,359 | $10,832 | 4.9% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 51 | 53 | $167,191 | $5,807 | 3.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2020 | 25 | 25 | $91,950 | $3,390 | 3.7% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2020 | 11 | 12 | $48,144 | $1,361 | 2.8% |
About Michael Khaham, D.O., RPH
Michael Khaham, D.O., RPH is a Pharmacist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790985596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Khaham, D.O., RPH has received a total of $207.57 in payments from pharmaceutical and medical device companies, with $73.90 received in 2023. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($207.57).
As a Medicare-enrolled provider, Khaham has provided services to 892 Medicare beneficiaries, totaling 1,263 services with total Medicare billing of $102,013. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Pharmacist
- Other Specialties Anesthesiology
- Location Brooklyn, NY
- Active Since 07/19/2007
- Last Updated 01/26/2015
- Taxonomy Code 183500000X
- Entity Type Individual
- NPI Number 1790985596
Products in Payments
- Sucraid (Drug) $53.53
- Movantik (Drug) $37.31
- XIFAXAN (Drug) $36.50
- TRULANCE (Drug) $35.23
- OCALIVA (Drug) $24.63
- CALDOLOR (Drug) $20.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pharmacist Doctors in Brooklyn
Russell Lukyanovsky, Rph, RPH
Pharmacist
Inna Lukyanovsky, Rph, Cgp, RPH, CGP
Pharmacist
Dr. Samantha Jellinek, Pharm.d., Bcps, PHARM.D., BCPS
Pharmacist
Dr. Victor Cohen, Pharmd, Bcps, PHARMD, BCPS
Pharmacist
Wendy Yuen
Pharmacist
Mahmood Alam, Rph, RPH
Pharmacist